Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 07658994
Vivek Ashwinkumar Pandya is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at AKRON CROWDSOURCE MANAGEMENT PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07658994.Vivek Ashwinkumar Pandya is currently involved in 3 different roles. Their most recent position is with M-MART PHARMACY LLP as a Designated Partner. The first company Vivek Ashwinkumar Pandya was appointed to as a director was AKRON CROWDSOURCE MANAGEMENT PRIVATE LIMITED. Vivek Ashwinkumar Pandya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vivek Ashwinkumar Pandya is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at AKRON CROWDSOURCE MANAGEMENT PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07658994.Vivek Ashwinkumar Pandya is currently involved in 3 different roles. Their most recent position is with M-MART PHARMACY LLP as a Designated Partner. The first company Vivek Ashwinkumar Pandya was appointed to as a director was AKRON CROWDSOURCE MANAGEMENT PRIVATE LIMITED. Vivek Ashwinkumar Pandya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (2)
Past Companies (0)
1y 10m 11 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
AKRON CROWDSOURCE MANAGEMENT PRIVATE LIMITED | Director | 09-Dec-2016 |
AKRON CROWDSOURCE MANAGEMENT PRIVATE LIMITED | Individual Promoter | 09-Dec-2016 |